{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:44:28Z","timestamp":1769208268236,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.leukres.2009.07.009","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T13:12:46Z","timestamp":1248873166000},"page":"123-127","source":"Crossref","is-referenced-by-count":45,"title":["Renal failure associated with tyrosine kinase inhibitors\u2014Case report and review of the literature"],"prefix":"10.1016","volume":"34","author":[{"given":"Anat","family":"Gafter-Gvili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Ram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzi","family":"Gafter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Shpilberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Raanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.07.009_bib1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM200104053441409","article-title":"Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Goldman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.07.009_bib2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.07.009_bib3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.07.009_bib4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200544090-00001","article-title":"Clinical pharmacokinetics of imatinib","volume":"44","author":"Peng","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.leukres.2009.07.009_bib5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O\u2019Brien","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.07.009_bib6","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.07.009_bib7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.07.009_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10637-005-4543-z","article-title":"Phase II trial of imatinib (Gleevec) in patients with metastatic renal cell carcinoma","volume":"24","author":"Vuky","year":"2006","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.leukres.2009.07.009_bib9","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/annonc\/mdf304","article-title":"Severe tumor lysis syndrome during treatment with STI 571 in a patient with chronic myelogenous leukemia accelerated phase","volume":"13","author":"Vora","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2009.07.009_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1200\/JCO.2002.20.1.354","article-title":"Tumor lysis syndrome after STI571 in Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"20","author":"Dann","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2009.07.009_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/ndt\/17.4.685","article-title":"Renal failure associated with a specific inhibitor of BCR-ABL tyrosine kinase, STI 571","volume":"17","author":"Kitiyakara","year":"2002","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.leukres.2009.07.009_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.leukres.2006.05.005","article-title":"Tumour lysis syndrome with acute renal failure during imatinib therapy","volume":"31","author":"Ali","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2009.07.009_bib13","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1080\/1042819031000079140","article-title":"Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia","volume":"44","author":"Pou","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2009.07.009_bib14","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1345\/aph.1G131","article-title":"Acute renal failure secondary to imatinib mesylate treatment in prostate cancer","volume":"39","author":"Foringer","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.leukres.2009.07.009_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.ajkd.2007.10.039","article-title":"Partial fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate loss","volume":"51","author":"Francois","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.leukres.2009.07.009_bib16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.2001.0590041324.x","article-title":"PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis","volume":"59","author":"Gilbert","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.leukres.2009.07.009_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.ki.5001528","article-title":"Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease","volume":"70","author":"Zoja","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.leukres.2009.07.009_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1681\/ASN.2004050392","article-title":"Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice","volume":"16","author":"Lassila","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.leukres.2009.07.009_bib19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/01.TP.0000062836.93496.CE","article-title":"Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy","volume":"75","author":"Savikko","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.leukres.2009.07.009_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/01.HYP.0000202487.68969.f7","article-title":"Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats","volume":"47","author":"Schellings","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.leukres.2009.07.009_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9440(10)63651-6","article-title":"Activation of Src kinase in platelet-derived growth factor-B-dependent tubular regeneration after acute ischemic renal injury","volume":"163","author":"Takikita-Suzuki","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.leukres.2009.07.009_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2710.2008.00873.x","article-title":"Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase","volume":"33","author":"Sonmez","year":"2008","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.leukres.2009.07.009_bib23","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1182\/blood-2006-11-056028","article-title":"Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial","volume":"109","author":"Kantarjian","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.07.009_bib24","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias","volume":"354","author":"Talpaz","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.07.009_bib25","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1182\/blood-2006-09-047266","article-title":"Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy","volume":"109","author":"Hochhaus","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.07.009_bib26","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood-2006-09-046839","article-title":"Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase","volume":"109","author":"Guilhot","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.07.009_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.leukres.2008.07.029","article-title":"Renal failure and recovery associated with second-generation Bcr-Abl kinase inhibitors in imatinib-resistant chronic myelogenous leukemia","volume":"33","author":"Holstein","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2009.07.009_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0960-9822(00)00024-5","article-title":"Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn","volume":"11","author":"Yu","year":"2001","journal-title":"Curr Biol"},{"key":"10.1016\/j.leukres.2009.07.009_bib29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/1078-0432.CCR-07-4175","article-title":"Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate","volume":"14","author":"Brave","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609003543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609003543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T19:19:18Z","timestamp":1558466358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609003543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0145212609003543"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.07.009","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}